The clinical measures in the 63 children with NAFLD were higher than those 63 healthy children, including height, weight, waist, hip, PBF, VFA, BMI, WBC, RBC, HGB, HCT, MONO, NEUT, IG, TG, ALP, CHE, GLB, TP, ALT, PA, and GGT, consistent with the NAFLD clinical expectations of these indicators. This evidence concerns the gene CYGB and metabolic dysfunction-associated steatotic liver disease.